PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
June 15, 2026Case Reports in Infectious Diseases0 citationsOpen Access

Breakthrough Pulmonary Nocardiosis Due to Nocardia cyriacigeorgica in a Lung Transplant Recipient in Brazil: A Case Report Highlighting Management Without Susceptibility Testing

View Full Paper
CVCaian L. VinhaesMGM. Gabriela GallegosJDJoana R. Deheinzelin

Key Points

  • To report a case of pulmonary nocardiosis in a lung transplant recipient and discuss management challenges.
  • Case presentation of a 45-year-old woman with cystic fibrosis post lung transplantation.
  • Diagnosis confirmed via bronchoalveolar lavage and sputum cultures.
  • Treatment administered with meropenem and trimethoprim-sulfamethoxazole.
  • Isolated Nocardia cyriacigeorgica from the patient’s respiratory samples.
  • Clinical and radiological improvement noted after treatment.
  • Highlights the diagnostic challenges and importance of awareness in transplant recipients.

Abstract

Background Nocardia infection is an emerging concern in solid organ recipients due to prolonged immunosuppression. Case Presentation We report the case of a 45‐year‐old woman with a history of cystic fibrosis who underwent bilateral lung transplantation. Eight years posttransplant, she developed progressive respiratory symptoms. Imaging revealed cavitary nodular lesions, and Nocardia cyriacigeorgica was isolated from bronchoalveolar lavage and sputum cultures. Treatment with meropenem and trimethoprim‐sulfamethoxazole led to clinical and radiological improvement. Conclusion This case highlights the diagnostic challenges of Nocardia infections, the importance of microbiological interpretation, and the potential for late‐onset disease in transplant recipients despite prophylaxis. Awareness of Nocardia as an opportunistic pathogen is crucial for timely diagnosis and management. Our findings underscore the need for continued vigilance in solid organ transplant recipients, particularly in cases of persistent pulmonary infections and high immunosuppressive therapy.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Vinhaes et al. (2026) studied this question.

synapsesocial.com/papers/6a2f9718a1cfeec4908283c1https://doi.org/10.1155/crdi/2026205
Ask AI
Helpful
Bookmark
Share
View Full Paper